“Major cancer centers, including Dana-Farber in Boston and the Moffitt Center in Florida, are pooling data collected by oncologists, and using computers to develop precise biomarker-based prescription protocols using existing FDA-approved drugs. Commercial vendors are also offering precision oncology services recommending treatment based on patients’ unique molecular profiles—regardless of what the drug’s FDA-approved label says.”
As reported previously, none of this fits into the vision of the Obamacare creators. Obamacare architect, Zeke Emanuel, for example has called personalized medicine a “myth” and even if it works, he says, we can’t afford it. Obamacare cheerleader Atul Gawande thinks that medicine should be more like engineering — with all doctors following the same script, rather than exercising their individual judgments. Karen Davis, another cheerleader, envisions a world in which doctors who follow the script get more pay, while those who deviate will be docked.